Biogen Inc. buy BMO Capital Markets
Start price
08.08.23
/
50%
€249.40
Target price
08.08.24
€306.84
Performance (%)
-25.40%
End price
09.08.24
€186.05
Summary
This prediction ended on 09.08.24 with a price of €186.05. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.40%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.710% | -0.710% | 61.297% |
| iShares Core DAX® | 1,84 % | 1,39 % | 8,65 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % | 27,82 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % | 51,81 % |
| iShares S&P 500 | 3,70 % | 1,58 % | 24,09 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $347.00 to $336.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten